gvtcx

supplier

Mylan

as a supplier

54 recorded awards from 10 buyers , between 21 Dec 2020 and 24 Jun 2025.

awards won
54
exclusive
4%
2 sole-winner awards
median award
£245.9m
largest
£480.4m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

buyerawards
NHS England 23
The NHS Commissioning Board (operating under the name of NHS England) 14
The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") 7
The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") 3
Atamis Ltd 2
Velindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards 1
Nhsei 1
The Common Services Industry (more commonly known as NHS National Services Scotland) ("NSS") 1
Velindre NHS Trust, NHS Wales Shared Services Parternship - Procurement Services (On Behalf of All Wales) Health Boards and Trusts 1
Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts 1

contracts won

contractbuyervalueawarded
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National shared NHS England £261,895,933 24 Jun 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared NHS England £1,241,520,444 24 Mar 2025
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 shared NHS England £626,522,476 28 Oct 2024
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1) shared NHS England £1 4 Mar 2024
CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins shared NHS England £186,609,000 13 Jul 2023
NHS National Generic Pharmaceuticals Wave 14b shared ATAMIS LTD £428,226,984 6 Jul 2023
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared NHS England £304,504,000 23 Apr 2023
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
National Procurement for HIV and Preventative Treatments shared NHSE&I £230,000,000 1 Feb 2022
NHS National Generic Pharmaceuticals Wave 13 shared ATAMIS LTD £469,741,550 30 Nov 2021
NHS National Generic Pharmaceuticals Interim 2 shared NHS England £12,327,097 21 Dec 2020
NHS National Generic Pharmaceuticals Wave 15b shared NHS England · 4 Aug 2025
NHS National Generic Pharmaceuticals Wave 15b shared NHS England · 4 Aug 2025
NHS National Framework for the supply of Generics Housekeeping / Supply Chain Resilience Products, commencing 1 June 2025 shared NHS England · 8 May 2025
NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 shared NHS England · 22 Apr 2025
NP31419 Clozapine Medicines The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · 21 Dec 2023
NHS National Pharmaceuticals Dasatinib and Paliperidone Injection shared NHS England · 27 Apr 2023
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals shared NHS England · 6 Apr 2023
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals shared NHS England · 6 Apr 2023
NHS Framework for Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England · 15 Mar 2023
NP47822 Multiple Sclerosis Medicines shared The Common Services Industry (more commonly known as NHS National Services Scotland) ("NSS") · 15 Feb 2023
NHS Framework Agreement for South of England Branded - Tranche B and Annual shared NHS England · 12 Aug 2022

every contract won by Mylan →